Dr Yvette Meißner appointed to the Lancet Rheumatology Commission on Reproductive Health
Epidemiologist from the DRFZ is a member of the Commission on family planning in immune-mediated long-term conditions Dr Yvette Meißner from the Pharmacoepidemiology Research Group…
Epidemiologist from the DRFZ is a member of the Commission on family planning in immune-mediated long-term conditions Dr Yvette Meißner from the Pharmacoepidemiology Research Group…
10,024 Kilometers for the Climate In 2026, the DRFZ once again actively participated in the “Stadtradeln – Cycling for the Climate” challenge: Over the course…
Researchers at the DRFZ, Charité and TU Berlin have identified a characteristic intestinal microbiota signature in patients with IgG4-related disease. Using single-cell analysis and machine…
Transferring Research Into Practice For Patients With Rheumatic Diseases Common press release (LIT & DRFZ) The Leibniz Institute for Immunotherapy (LIT) and the German Rheumatology…
Statement by the German Network for Health Services Research regarding cuts to funding for the Innovation Fund On April 29, 2026, the Cabinet passed the…